Generics
65,800+ finished dosage formulation products
Innovative
30+ products
Biosimilars
100+ products
By company type
By departments
Generics
65,800+ finished dosage formulation products
Innovative
30+ products
Biosimilars
100+ products
Medical devices
500+ products
Nutraceuticals
5700+ products
72,200+
finished dosage formulation products
100+
countries of production
2,000+
dossier owners and CDMOs
90%+
reply rate
Definitions: reply rate — Share of business inquiries sent through the platform that received a substantive reply from the recipient within 30 days, measured over the trailing 12 months. Search success rate — Share of product searches on the platform that return at least one matching product or supplier, measured over the trailing 12 months. As of October 2026.
Simplify product discovery with the largest EU CTD dossier database. Expert curated, up-to-date information. Powerful search engine and product filters.
Discover high-quality products
Reduce time-to-contract by finding qualified manufacturers. Share your business case and connect with suppliers directly.
We assist you in discovering new products, matching with potential qualified manufacturers, and making the deals happen.
Number of registered companies as of October 2026.
“A remarkable success. In less than three months we formalised a contract for four products and started receiving shipments promptly — with further collaborations already in discussion.”
“A responsive, user-friendly platform that streamlined our sourcing and supplier connections. We’ve established relationships with two companies and have three more agreements nearing finalization.”
“The Subscription plan has greatly benefited our portfolio expansion. We’ve made significant progress securing contracts with several introduced suppliers. The user-friendly database and supportive team make it highly recommended.”
“Within days we connected with multiple qualified CTD dossier owners and manufacturers, allowing us to secure new contracts. The platform consistently provides valuable business opportunities to grow our network.”
“Exceptional. Within days of activating our subscription we connected with qualified owners and manufacturers for targeted products we couldn’t develop in-house — expanding our pipeline while reducing sourcing time and cost.”
“Pipelinepharma’s pipeline intelligence and CTD dossier sourcing have become valuable additional instrument and asset to building our product portfolio. Easy to navigate, reliable sources, traceable process - reasons enough to renew our subscription.”